Extending Our Global Footprint in Life Sciences
Blog post from Box
Box has significantly expanded its investment in the life sciences industry over the past three years, supporting digital transformation efforts for over 650 organizations, including major pharmaceutical companies like GlaxoSmithKline and Eli Lilly. The company has strengthened its presence in the Japanese market with new clients such as Daichi Sankyo and Shionogi and is collaborating with partners like CHITA, Prolifiq, USDM, and CTCLS to enhance its offerings. These partnerships aim to provide comprehensive content management and collaboration solutions tailored to the life sciences sector, focusing on regulated and non-regulated content management, sales enablement, and migration to cloud-based systems. The integration with leading Independent Software Vendors (ISVs) and System Integrators (SIs) allows Box to deliver specialized workflows, ensuring compliance and facilitating seamless collaboration across the industry. With its user-friendly platform, Box continues to innovate and offer unique solutions for managing sensitive content, thereby maintaining a high level of compliance and security for its life sciences clients.
No tracked trend matches for this post yet.
Use this post, company, and trend context to find content marketing opportunities, perform competitive analysis, or address product feature gaps via the Plushcap MCP server or the Plushcap API.